Why the study?
Does nesiritide lower filling pressures and achieve diuresis in a patient with postoperative heart failure after mitral valve replacement?
Does nesiritide lower filling pressures and achieve diuresis in a patient with postoperative heart failure after mitral valve replacement?
Nesiritide may be a useful therapeutic option for managing postoperative heart failure and cardiogenic shock following high-risk cardiac surgery.
Answers are grounded in this paper and cite their sources.
Nesiritide may aid diuresis in post-MVR HF; hypothesis-generating and requires RCTs before practice change.
Nesiritide is primarily used in the treatment of acutely decompensated chronic heart failure. It may also be useful in the postoperative management of patients with an exacerbation of heart failure after cardiac surgery. The management of a patient with cardiogenic shock after acute papillary muscle rupture is described. The patient exhibited signs of postoperative heart failure, and nesiritide therapy was instituted to lower filling pressures and achieve diuresis. This drug may be useful when patients with heart failure undergo cardiac surgery and continue to show evidence of heart failure in the postoperative period.
No takes yet. Share an insight, caveat, or question.
Entwistle et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: